Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury

Annals of Surgery

Volumn 235, Issue 4, 2002, Pages 568-578

  Liaudet, Lucas ^a,b   Mabley, Jon G ^a   Pacher, Pál ^a   Virág, László ^a   Soriano, Francisco G ^a   Marton, Anita ^a   Haskó, György ^a,b   Deitch, Edwin A ^b   Szabó, Csaba ^a,b  

^a INOTEK CORPORATION   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; INOSINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; MYELOPEROXIDASE; NITRIC OXIDE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVITY; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LEUKOCYTE COUNT; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; ESCHERICHIA COLI; HUMANS; INOSINE; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED BALB C; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0036203190     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200204000-00016     Document Type: Article

References (57)

1. The American-European Consensus Conference on ARDS, part 2: Ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome
2. The acute respiratory distress syndrome
3. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury
4. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide
5. 2 integrin-dependent mechanism
6. Cytokines and the acute respiratory distress syndrome (ARDS): A question of balance
7. Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1
8. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury
9. Oxidant-mediated lung injury in the acute respiratory distress syndrome
10. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo
11. Adenoviral E3-14.7K protein in LPS-induced lung inflammation
12. Thiol-mediated regulation of ICAM-1 expression in endotoxin-induced acute lung injury
13. Purine nucleotide metabolism in resident and activated rat macrophages in vitro
14. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation
15. Adenosine and inosine increase cutaneous vasopermeability by activating A(3) receptors on mast cells
16. Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock
17. A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis
18. Inosine improves gut permeability and vascular reactivity in endotoxic shock
19. Action of purine nucleosides on the release of intracellular enzymes from rat lymphocytes
20. Effects of purine and pyrimidine nucleotides on intracellular Ca in human eosinophils: Activation of purinergic P2Y receptors
21. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells
22. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
23. Metabolism of circulating adenosine by the porcine isolated perfused lung
24. Positive inotropic response to inosine in the in situ canine heart
25. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase
26. Biology of nitric oxide signaling
27. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia
28. Lung cytokines and ARDS: Roger S. Mitchell lecture
29. Chemokines in lung injury: Thomas A. Neff lecture
30. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury
31. G-CSF, IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome
32. High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome
33. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
34. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury
35. Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS
36. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality
37. Acid-induced lung injury. Protective effect of anti-interleukin-8 pretreatment on alveolar epithelial barrier function in rabbits
38. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms
39. Macrophage inflammatory protein-1 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia
40. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome
41. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time
42. Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2
43. IL-4 inhibits the expression of IL-8 from stimulated human monocytes
44. IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma
45. Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury
46. Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury
47. Effect of uric acid on liver injury during hemorrhagic shock
48. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A hypothesis
49. Uric acid as radical scavenger and antioxidant in the heart
50. Structural alterations of lung parenchyma in the adult respiratory distress syndrome
51. Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functions
52. Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death
53. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion
54. Inosine supplementation has no effect on aerobic or anaerobic cycling performance
55. Effect of inosine supplementation on 3-mile treadmill run performance and VO2 peak
56. Effect of inosine supplementation on aerobic and anaerobic cycling performance
57. Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture